Target intelligence / Profile preview

Skeletal and cardiac muscle fibers

Molecular classification
Other
01

Overview

Skeletal and cardiac muscle fibers are the fundamental contractile units of striated muscle tissue, specialized for converting chemical energy into mechanical force. Skeletal muscle fibers are large, multinucleated cells that facilitate voluntary movement and maintain posture under the control of the somatic nervous system (StatPearls, 2023). In contrast, cardiac muscle fibers, or cardiomyocytes, are branched cells connected by intercalated discs that ensure synchronized, involuntary contraction of the heart for blood circulation (NIH, 2023). Both fiber types utilize a highly organized sarcomeric structure composed of actin and myosin filaments, where contraction is triggered by an increase in intracellular calcium—a process known as excitation-contraction coupling. While 'muscle fibers' represent a tissue or cellular level of organization rather than a single molecular target, they contain numerous specific proteins such as Ryanodine receptors, L-type calcium channels, and Myosin isoforms that are critical therapeutic targets for treating heart failure, arrhythmias, and various myopathies (PubMed, 2022). Consequently, pharmacological interventions involving these fibers typically aim to modulate calcium sensitivity, stabilize electrical activity, or enhance the mechanical efficiency of motor proteins.

Other names
Striated muscle fibersMyocytesMuscle cellsStriated myocytesSkeletal muscle cellsCardiomyocytes
02

Mechanism of action

Drugs interact with specific molecular components within these fibers, such as ion channels (sodium, potassium, calcium), ryanodine receptors, or contractile proteins (myosin, troponin), to modulate contraction, relaxation, and electrical excitability (PubMed, 2022).

03

Biological functions

Muscle contractionLocomotionCirculationThermogenesisMetabolic regulationPostural maintenance
04

Disease associations

Muscular dystrophyHeart failureMyocardial infarctionArrhythmiaMyopathySarcopeniaMyasthenia gravis
05

Safety considerations

RhabdomyolysisCardiotoxicityArrhythmogenesisMuscle weaknessElectrolyte disturbancesMalignant hyperthermia
06

Interacting drugs

Digoxin

7 more in the full profile.

07

Biomarkers

Creatine kinase (CK)Cardiac troponin I (cTnI)Cardiac troponin T (cTnT)MyoglobinBrain natriuretic peptide (BNP)N-terminal pro-b-type natriuretic peptide (NT-proBNP)

Beyond the preview

Go deeper on Skeletal and cardiac muscle fibers.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Skeletal and cardiac muscle fibers.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call